[Abortion induced by mifepristone and sulprostone combination: attempting analgesia with acetominophen or dipropyline].
Weber
B
B
Fontan
J E
JE
Scheller
E
E
Debu
E
E
Dufour
B
B
Majorel
P
P
Langlade
A
A
D000028:Abortion, Induced; D000698:Analgesia; D001695:Biology; D003710:Demography; D019049:Developed Countries; D004194:Disease; D004311:Double-Blind Method; D004703:Endocrine System; D005060:Europe; D005193:Family Planning Services; D005602:France; D006727:Hormone Antagonists; D006728:Hormones; D015735:Mifepristone; D010146:Pain; D010827:Physiology; D011153:Population; D011157:Population Dynamics; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011453:Prostaglandins; D011465:Prostaglandins, Synthetic; D012098:Reproduction; D012106:Research; D012816:Signs and Symptoms; D013812:Therapeutics; D013997:Time Factors
D006727:Hormone Antagonists; D006728:Hormones; D011453:Prostaglandins; D011465:Prostaglandins, Synthetic; D015735:Mifepristone
Abortion, Induced; Analgesia; Biology; Demographic Factors; Developed Countries; Diseases; Double-blind Studies; Endocrine System; Europe; Family Planning; Fertility Control, Postconception; France; Hormone Antagonists; Hormones; Mediterranean Countries; Pain; Physiology; Population; Population Dynamics; Pregnancy; Pregnancy, First Trimester; Prostaglandins; Prostaglandins, Synthetic; Reproduction; Research Methodology; Ru-486--administraction and dosage; Signs And Symptoms; Studies; Time Factors; Treatment; Western Europe